Analyst consensus rating
Moderna Analyst Rating: Hold
Direct answer
Moderna's consensus rating is Hold.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $138.37.
Forecast evidence checked November 1, 2026.
Get free Moderna email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $221.72
- Average price target
- $138.37
- High price target
- $251.00
- Low price target
- $45.00
- Low target gap
- -79.7%
- Target upside
- -37.6%
- High target gap
- +13.2%
- Target range width
- 92.9%
- Consensus rating
- Hold
- Analysts
- 19
- Evidence date
- November 1, 2026
- Valid through
- November 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Moderna?
Moderna has a verified Hold consensus. The same dataset has an average price target of $138.37.
How far are Moderna's low and high targets from the recorded price?
The low target implies -79.7%, while the high target implies +13.2%.
How many analysts are included in Moderna's consensus?
The verified consensus includes 19 analysts.
How is Moderna's target upside or downside calculated?
The average target of $138.37 is divided by the recorded price of $221.72, then one is subtracted to produce -37.6%. This does not guarantee a future return.
When was Moderna's analyst forecast verified?
The data was verified on 2026-11-01. The dataset is valid through 2026-11-08.